Statistical analysis plan for the ‘Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2)’

Rationale: Glyceryl trinitrate, a nitric oxide donor, is a candidate treatment for acute stroke; it lowers blood pressure, does not alter cerebral blood flow or platelet function and is neuroprotective in experimental stroke. The ongoing rapid intervention with glyceryl trinitrate in hypertensive stroke trial-2 trial aims to assess the safety and efficacy of paramedic-delivered glyceryl trinitrate in patients with ultra-acute stroke. Aims and design: The rapid intervention with glyceryl trinitrate in hypertensive stroke trial-2 trial is a multicentre UK-based prospective randomised sham-controlled outcome-blinded parallel-group trial in patients with presumed stroke who present to the ambulance service following a 999 emergency call. The primary outcome is the modified Rankin scale measured by central telephone follow-up at 90 days. Results This paper describes the statistical analysis plan for the rapid intervention with glyceryl trinitrate in hypertensive stroke trial-2 trial and was developed prior to unblinding to treatment allocation. The statistical analysis plan includes details of methods for analyses and unpopulated tables and figures to be included in the primary and other secondary publications. Discussion Statistical analysis plan details what analyses will be done prior to unblinding to treatment allocation to avoid bias in the findings. Rapid intervention with glyceryl trinitrate in hypertensive stroke trial-2 trial will determine whether glyceryl trinitrate administered ultra-acutely can improve outcome after stroke. The rapid intervention with glyceryl trinitrate in hypertensive stroke trial-2 trial is registered as ISRCTN26986053.

[1]  S. Pocock,et al.  Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053) , 2019, International journal of stroke : official journal of the International Stroke Society.

[2]  M. Endres,et al.  Functional outcomes of pre-hospital thrombolysis in a mobile stroke treatment unit compared with conventional care: an observational registry study , 2016, The Lancet Neurology.

[3]  A. Demchuk,et al.  Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials , 2016, The Lancet.

[4]  C. Anderson,et al.  Effect of Treatment Delay, Stroke Type, and Thrombolysis on the Effect of Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome after Acute Stroke: A Systematic Review and Meta-Analysis of Individual Patient from Randomised Trials , 2016, Stroke research and treatment.

[5]  J. Wardlaw,et al.  Effect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome After Stroke: Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial , 2015, Stroke.

[6]  Stephanie Oberfoell.  Prehospital Use of Magnesium Sulfate as Neuroprotection in Acute Stroke , 2015 .

[7]  E. T. Investigators,et al.  Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial , 2015, The Lancet.

[8]  P. Sandercock,et al.  Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials | NOVA. The University of Newcastle's Digital Repository , 2014 .

[9]  D. Krieger,et al.  European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage , 2014, International journal of stroke : official journal of the International Stroke Society.

[10]  S. Pocock,et al.  Statistical analysis plan for the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) trial , 2014, International journal of stroke : official journal of the International Stroke Society.

[11]  H. Bøtker,et al.  Remote Ischemic Perconditioning as an Adjunct Therapy to Thrombolysis in Patients With Acute Ischemic Stroke , 2013 .

[12]  P. Bath,et al.  Feasibility of an Ambulance-Based Stroke Trial, and Safety of Glyceryl Trinitrate in Ultra-Acute Stroke: The Rapid Intervention With Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824) , 2013, Stroke.

[13]  L. Shaw,et al.  Paramedic Initiated Lisinopril For Acute Stroke Treatment (PIL-FAST): results from the pilot randomised controlled trial , 2013, Emergency Medicine Journal.

[14]  M. Woodward,et al.  Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. , 2013, The New England journal of medicine.

[15]  Hsin-Chieh Yeh,et al.  Effect of the 2011 vs 2003 duty hour regulation-compliant models on sleep duration, trainee education, and continuity of patient care among internal medicine house staff: a randomized trial. , 2013, JAMA internal medicine.

[16]  P. Bath,et al.  Determining the Feasibility of Ambulance-Based Randomised Controlled Trials in Patients with Ultra-Acute Stroke: Study Protocol for the “Rapid Intervention with GTN in Hypertensive Stroke Trial” (RIGHT, ISRCTN66434824) , 2012, Stroke research and treatment.

[17]  D. Fatovich,et al.  Thrombolysis in acute ischaemic stroke , 2012, The Lancet.

[18]  I. Grunwald,et al.  Mobile stroke unit for diagnosis-based triage of persons with suspected stroke , 2012, Neurology.

[19]  Klaus Fassbender,et al.  Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial , 2012, The Lancet Neurology.

[20]  P. Sandercock,et al.  The International Stroke Trial database , 2011, Trials.

[21]  P. Bath,et al.  Current Therapeutic Strategies to Mitigate the eNOS Dysfunction in Ischaemic Stroke , 2012, Cellular and Molecular Neurobiology.

[22]  L. Shaw,et al.  Paramedic Initiated Lisinopril For Acute Stroke Treatment (PIL-FAST): study protocol for a pilot randomised controlled trial , 2011, Trials.

[23]  M. Castrén,et al.  Strict glucose control after acute stroke can be provided in the prehospital setting. , 2011, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[24]  H. Diener,et al.  Influence of Age on Outcome From Thrombolysis in Acute Stroke: A Controlled Comparison in Patients From the Virtual International Stroke Trials Archive (VISTA) , 2010, Stroke.

[25]  C. Anderson,et al.  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2010, Stroke.

[26]  P. Bath,et al.  Interventions for Deliberately Altering Blood Pressure in Acute Stroke , 2014, The Cochrane database of systematic reviews.

[27]  J. Grotta,et al.  The Virtual International Stroke Trials Archive , 2007, Stroke.

[28]  Jeb Palmer,et al.  The NeuroGrid Stroke Exemplar Clinical Trial Protocol , 2007, International journal of stroke : official journal of the International Stroke Society.

[29]  D. Leys,et al.  Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial , 2006, Journal of hypertension.

[30]  J. Wardlaw,et al.  Transdermal Glyceryl Trinitrate Lowers Blood Pressure and Maintains Cerebral Blood Flow in Recent Stroke , 2006, Hypertension.

[31]  P. Bath,et al.  A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. , 2005, Nitric oxide : biology and chemistry.

[32]  M. Edwards,et al.  Trial , 2004, The Lancet.

[33]  Jeffrey L. Saver,et al.  Prehospital Neuroprotective Therapy for Acute Stroke: Results of the Field Administration of Stroke Therapy–Magnesium (FAST–MAG) Pilot Trial , 2004, Stroke.

[34]  J. Leonardi-Bee,et al.  High blood pressure in acute stroke and subsequent outcome: a systematic review. , 2004, Hypertension.

[35]  J. Leonardi-Bee,et al.  The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. , 2003, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[36]  P. Bath,et al.  The potential of nitric oxide therapeutics in stroke , 2003, Expert opinion on investigational drugs.

[37]  A. Whitehurst,et al.  Plasma nitric oxide (nitrate/nitrite) levels in acute stroke and their relationship with severity and outcome. , 2003, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[38]  P. Sandercock,et al.  Blood Pressure and Clinical Outcomes in the International Stroke Trial , 2002, Stroke.

[39]  J. Leonardi-Bee,et al.  Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke. , 2002, The Cochrane database of systematic reviews.

[40]  P. Bath,et al.  The Effect of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Blood Pressure and Platelet Function in Acute Stroke , 2001, Cerebrovascular Diseases.

[41]  R. Collins,et al.  Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials , 2001, The Lancet.